Dr. Reddy’s launches febuxostat tablets
PRINCETON, N.J. — Dr. Reddy’s Laboratories announced the launch of febuxostat tablets, a therapeutic equivalent generic version of Uloric (febuxostat) tablets approved by the U.S. Food and Drug Administration (USFDA). The Uloric brand and generic had U.S. sales of approximately $108 million MAT for the most recent twelve months ending in October 2020 according to
